Showing results (491-500 of 524) with videos related to

Sort By:
Pageof 53
Neuron|August 20, 2019
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived NeuronsRuilin Tian, Mariam A Gachechiladze, Connor H Ludwig, et al.
BMC Medical Genomics|July 9, 2020
Mitochondrial GWAS and association of nuclear - mitochondrial epistasis with BMI in T1DM patientsAgnieszka H Ludwig-Słomczyńska, Michał T Seweryn, Przemysław Kapusta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Predictive role of interphase cytogenetics for survival of patients with multiple myelomaR Königsberg, N Zojer, J Ackermann, et al.
Journal of Diabetes Research|November 4, 2016
Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes MellitusSandra Mrozinska, Piotr Radkowski, Tomasz Gosiewski, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Journal of Lipid Research|January 18, 2005
High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteinsMatthias Schneider, Joseph L Witztum, Stephen G Young, et al.
Thrombosis Research|September 10, 2014
Lupus anticoagulant and thrombosis in splenic marginal zone lymphomaJ Gebhart, K Lechner, C Skrabs, et al.
Molecular Medicine (Cambridge, Mass.)|September 14, 2022
Variants influencing age at diagnosis of HNF1A-MODYAgnieszka H Ludwig-Słomczyńska, Michał T Seweryn, Piotr Radkowski, et al.
Leukemia & Lymphoma|March 26, 2002
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-CW Hilbe, T Kühr, U Apfelbeck, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
Pageof 53